Venetoclax is an anti-cancer and precision therapy. Also, it can treat various blood cancers. This medicine decreases cancer progression and growth in the body. On the other hand, the medicine can have certain side effects. However, it can be managed without the need for medical oversight. Moreover, it works by locking onto proteins which induce cancer growth.
Understanding Blood Cancers and the Need for Targeted Therapy
Blood cancers damage the body’s normal blood cell production in the bone marrow. Furthermore, therapies like chemotherapies destroy cancerous and healthy cells. Thus, doctors depend on targeted therapies because they target specific factors. Also, these factors include mutations, proteins and gene abnormalities. Therefore, this specific action spares healthy cells and causes minimal side effects.
Understanding the Role of BCL-2 in Blood Cancers
BCL-2 protein is responsible for preventing cancer cell death. Moreover, it can improve cancer growth and division. In cancers, mutations in genes lead to the production of proteins that are overexpressed. Therefore, blood cancers use these proteins to survive and divide rapidly inside the body.
What Is Venetoclax?
Venetoclax is a targeted prescription cancer medicine which treats multiple cancers. Moreover, it targets blood cancers like CLL, SLL and AML. This medicine comes in the form of tablets and is taken orally. In addition, doctors advise taking these medicines with a meal or water. Also, the treatment starts off with a lower dosage and increases gradually.
How Does Venetoclax Work?
It works by blocking the BCL-2 (B-cell lymphoma-2) protein, which prevents cancer death. Moreover, it can promote cancer growth and spread. Thus, after blocking the cancer, starve and die off naturally. Also, it can reduce cancer load and cells in the body.
Why are blood cancers commonly associated with venetoclax?
These blood cancers rely on BCL-2 proteins which help them in survival and growth. Moreover, the medicine can stop the cancer cells from going under programmed cell death. On the other hand, the medicine targets these proteins and spares the healthy cells. Thus, patients use Venetoclax for treating multiple conditions of blood cancer.
Why do doctors consider venetoclax a breakthrough?
This medicine is the first targeted therapy to block the BCL-2 protein. Most cancers produce such proteins for survival. Yet, the medicine stops this process and causes the cancer cells to self-destruct.
Benefits of Venetoclax Therapy
There are certain benefits, like:
- Delay cancer progression
- Decrease cancer load
- Reduce cancer spread
- Lowers tumor size
Possible Side Effects of Venetoclax
There are some side effects which need monitoring. However, most of the side effects leave the body when the medicine starts working. The side effects are as follows:
Common side effects
- Low white blood cell counts
- Anemia
- Diarrhea
- Nausea
- Constipation
- Tiredness
- Joint pain
- Swelling
Serious side effects
- Tumor Lysis Syndrome
- Severe Infections
- Febrile Neutropenia
What are the brands?
Interaction with other medicines
Venetoclax interacts with different medicines to increase the overall effect. Moreover, it can combine with Rituximab (Rituxirel 100mg/10ml Injection). This can enhance immune targeting of cancer cells. It can interact with hypomethylating agents like azacitidine (Azadine 100mg Injection).
Conclusion
Doctors use Venetoclax for targeted precision therapy to treat blood cancers. Moreover, it can aid in delaying the cancer progression and spread. These cancers overexpress BCL-2 proteins which promote cancer growth. Therefore, the medicine blocks these proteins from functioning. This action starves the cancer and causes programmed cell death. Finally, patients need to be careful with handling and usage of these medicines. It can affect the body when used in different combinations.
FAQs
Why does the venetoclax dosage start at a lower dose?
The medicine follows a dose ramp-up administration. Moreover, it is used to prevent tumour lysis syndrome. This can help doctors to avoid serious side effects.
Why is this medicine known as precision therapy?
The medicine can target specific proteins which drive cancer growth. Furthermore, it can precisely target cancer cells and spare healthy cells in the process.
References
- Deeks, E. D. (2016). Venetoclax: first global approval. Drugs, 76(9), 979-987. https://link.springer.com/article/10.1007/s40265-016-0596-x
- Lasica, M., & Anderson, M. A. (2021). Review of venetoclax in CLL, AML and multiple myeloma. Journal of Personalized Medicine, 11(6), 463. https://www.mdpi.com/2075-4426/11/6/463
- Lee, J. S., Roberts, A., Juarez, D., Vo, T. T. T., Bhatt, S., Herzog, L. O., … & Fruman, D. A. (2018). Statins enhance efficacy of venetoclax in blood cancers. Science translational medicine, 10(445), eaaq1240. https://www.science.org/doi/abs/10.1126/scitranslmed.aaq1240
- Scheffold, A., Jebaraj, B. M. C., & Stilgenbauer, S. (2018). Venetoclax: targeting BCL2 in hematological cancers. Small Molecules in Hematology, 215-242. https://link.springer.com/chapter/10.1007/978-3-319-91439-8_11
- Yan, Y., Guo, Y., Wang, Z., He, W., Zhu, Y., Zhao, X., … & Wang, Y. (2024). Clinical pharmacology and side effects of venetoclax in hematologic malignancies. Current Drug Metabolism. https://www.benthamdirect.com/content/journals/cdm/10.2174/0113892002338926241114080504
